Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan

被引:0
作者
Chun-Yi Lu
Ching-Hu Chung
Li-Min Huang
Eliza Kruger
Seng-Chuen Tan
Xu-Hao Zhang
Nan-Chang Chiu
机构
[1] National Taiwan University Children’s Hospital,
[2] Mackay Medical College,undefined
[3] IQVIA Inc,undefined
[4] GSK,undefined
[5] Mackay Children’s Hospital,undefined
来源
Cost Effectiveness and Resource Allocation | / 18卷
关键词
Pneumococcal conjugate vaccines; Taiwan; Synflorix; Prevenar 13; Invasive pneumococcal disease; Acute otitis media; Cost-effectiveness analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 335 条
[1]  
Erwin AL(2007)Nontypeable Trends Microbiol 15 355-362
[2]  
Smith AL(2003): understanding virulence and commensal behavior Current opinion in infectious diseases 16 129-134
[3]  
Murphy TF(2014)Respiratory infections caused by non-typeable Vaccine 32 3345-3349
[4]  
Chiang C-S(2019)National surveillance of invasive pneumococcal diseases in Taiwan, 2008–2012: differential temporal emergence of serotype 19A Clin Infect Dis 69 1581-541
[5]  
Chen Y-Y(2012)Successful control of J Formos Med Assoc 111 536-748
[6]  
Jiang S-F(2006) 19A replacement with a catch-up primary vaccination program in Taiwan Lancet 367 740-2689
[7]  
Liu D-P(2014)Epidemiological and microbiological characteristics of culture-proven acute otitis media in Taiwanese children PLoS Med 11 e1001657-471
[8]  
Kao P-H(2015)Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Canada Vaccine 33 2684-76
[9]  
Teng H-J(2014) and non-typable Lancet Respir Med 2 464-345
[10]  
Lu CY(2015): a randomised double-blind efficacy study PLoS ONE 10 e0120290-94